Other formats:
BibTeX
LaTeX
RIS
@article{1366193,
author = {Varun, Divya and Srinivasan, Gayathri Rajaram and Tsai, YiandHuan and Kim, HyunandJe and Cutts, Joshua and Petty, Francis and Merkley, Ryan and Stephanopoulos, Nicholas and Doležalová, Dáša and Marsala, Martin and Brafman, David A.},
article_location = {Oxford},
article_number = {"neuvedeno"},
doi = {http://dx.doi.org/10.1016/j.actbio.2016.10.037},
keywords = {Human pluripotent stem cells; Human neural progenitor cells; Peptide; Defined conditions},
language = {eng},
issn = {1742-7061},
journal = {Acta Biomaterialia},
title = {A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs)},
volume = {48},
year = {2017}
}
TY - JOUR
ID - 1366193
AU - Varun, Divya - Srinivasan, Gayathri Rajaram - Tsai, Yi-Huan - Kim, Hyun-Je - Cutts, Joshua - Petty, Francis - Merkley, Ryan - Stephanopoulos, Nicholas - Doležalová, Dáša - Marsala, Martin - Brafman, David A.
PY - 2017
TI - A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs)
JF - Acta Biomaterialia
VL - 48
IS - "neuvedeno"
SP - 120-130
EP - 120-130
PB - Elsevier BV
SN - 17427061
KW - Human pluripotent stem cells
KW - Human neural progenitor cells
KW - Peptide
KW - Defined conditions
N2 - Despite therapeutic advances, neurodegenerative diseases and disorders remain some of the leading causes of mortality and morbidity in the United States. Therefore, cell-based therapies to replace lost or damaged neurons and supporting cells of the central nervous system (CNS) are of great therapeutic interest. To that end, human pluripotent stem cell (hPSC) derived neural progenitor cells (hNPCs) and their neuronal derivatives could provide the cellular ‘raw material’ needed for regenerative medicine therapies for a variety of CNS disorders. In addition, hNPCs derived from patient-specific hPSCs could be used to elucidate the underlying mechanisms of neurodegenerative diseases and identify potential drug candidates. However, the scientific and clinical application of hNPCs requires the development of robust, defined, and scalable substrates for their long-term expansion and neuronal differentiation. In this study, we rationally designed a vitronectin-derived peptide (VDP) that served as an adhesive growth substrate for the long-term expansion of several hNPC lines. Moreover, VDP-coated surfaces allowed for the directed neuronal differentiation of hNPC at levels similar to cells differentiated on traditional extracellular matrix protein-based substrates. Overall, the ability of VDP to support the long-term expansion and directed neuronal differentiation of hNPCs will significantly advance the future translational application of these cells in treating injuries, disorders, and diseases of the CNS.
ER -
VARUN, Divya, Gayathri Rajaram SRINIVASAN, Yi-Huan TSAI, Hyun-Je KIM, Joshua CUTTS, Francis PETTY, Ryan MERKLEY, Nicholas STEPHANOPOULOS, Dáša DOLEŽALOVÁ, Martin MARSALA and David A. BRAFMAN. A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs). \textit{Acta Biomaterialia}. Oxford: Elsevier BV, 2017, vol.~48, ''neuvedeno'', p.~120-130. ISSN~1742-7061. Available from: https://dx.doi.org/10.1016/j.actbio.2016.10.037.
|
